First Citizens Bank & Trust’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.04M | Buy |
3,763
+61
| +2% | +$34.4K | 0.03% | 216 |
|
|
2026
Q1 | $2.2M | Sell |
3,702
-154
| -4% | -$76.7K | 0.05% | 195 |
|
|
2025
Q4 | $1.88M | Sell |
3,856
-1,295
| -25% | -$603K | 0.04% | 208 |
|
|
2025
Q3 | $2.16M | Buy |
5,151
+144
| +3% | +$48.4K | 0.05% | 182 |
|
|
2025
Q2 | $1.44M | Buy |
5,007
+2,408
| +93% | +$720K | 0.03% | 227 |
|
|
2025
Q1 | $801K | Sell |
2,599
-197
| -7% | -$67.5K | 0.02% | 258 |
|
|
2024
Q4 | $987K | Buy |
2,796
+115
| +4% | +$42.3K | 0.02% | 237 |
|
|
2024
Q3 | $961K | Buy |
2,681
+48
| +2% | +$16.2K | 0.02% | 244 |
|
|
2024
Q2 | $839K | Buy |
2,633
+375
| +17% | +$99.3K | 0.02% | 255 |
|
|
2024
Q1 | $519K | Buy |
2,258
+348
| +18% | +$78.5K | 0.01% | 315 |
|
|
2023
Q4 | $420K | Buy |
+1,910
| New | +$440K | 0.01% | 268 |
|
|
2019
Q2 | – | Sell |
-2,939
| Closed | -$345K | – | 440 |
|
|
2019
Q1 | $345K | Buy |
2,939
+946
| +47% | +$110K | 0.04% | 331 |
|
|
2018
Q4 | $217K | Buy |
+1,993
| New | +$231K | 0.03% | 372 |
|
|
2018
Q1 | – | Sell |
-2,190
| Closed | -$324K | – | 434 |
|
|
2017
Q4 | $324K | Sell |
2,190
-254
| -10% | -$32.3K | 0.04% | 274 |
|
|
2017
Q3 | $286K | Sell |
2,444
-584
| -19% | -$74.6K | 0.04% | 339 |
|
|
2017
Q2 | $393K | Buy |
3,028
+715
| +31% | +$89.2K | 0.05% | 310 |
|
|
2017
Q1 | $313K | Sell |
2,313
-221
| -9% | -$33.5K | 0.04% | 348 |
|
|
2016
Q4 | $363K | Sell |
2,534
-1,150
| -31% | -$147K | 0.04% | 287 |
|
|
2016
Q3 | $435K | Buy |
3,684
+50
| +1% | +$6.01K | 0.04% | 297 |
|
|
2016
Q2 | $385K | Sell |
3,634
-922
| -20% | -$103K | 0.03% | 345 |
|
|
2016
Q1 | $508K | Buy |
4,556
+2,422
| +113% | +$306K | 0.04% | 267 |
|
|
2015
Q4 | $334K | Sell |
2,134
-80
| -4% | -$11.6K | 0.02% | 306 |
|
|
2015
Q3 | $291K | Sell |
2,214
-189
| -8% | -$30.3K | 0.02% | 322 |
|
|
2015
Q2 | $418K | Sell |
2,403
-887
| -27% | -$160K | 0.03% | 318 |
|
|
2015
Q1 | $567K | Sell |
3,290
-39
| -1% | -$5.95K | 0.04% | 283 |
|
|
2014
Q4 | $431K | Buy |
3,329
+632
| +23% | +$81.4K | 0.03% | 247 |
|
|
2014
Q3 | $347K | Buy |
2,697
+14
| +0.5% | +$1.44K | 0.03% | 255 |
|
|
2014
Q2 | $237K | Buy |
+2,683
| New | +$258K | 0.02% | 299 |
|
|
2013
Q4 | – | Sell |
-4,382
| Closed | -$346K | – | 780 |
|
|
2013
Q3 | $346K | Sell |
4,382
-30
| -0.7% | -$2.19K | 0.01% | 871 |
|
|
2013
Q2 | $290K | Buy |
+4,412
| New | +$284K | 0.01% | 894 |
|
Other funds holding UTHR
ACA
JT
First Citizens Bank & Trust's UTHR Position: Q2 2026 in Review
First Citizens Bank & Trust increased its United Therapeutics (UTHR) stake by 1.6% in Q2 2026, buying an estimated $34.4K and bringing the position to 3,763 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #216.
First Citizens Bank & Trust first reported a position in UTHR in Q2 2013 and has held it in 30 quarters since. The position peaked at $2.2M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- First Citizens Bank & Trust held 3,763 shares of United Therapeutics worth $2.04M as of Q2 2026.
- First Citizens Bank & Trust bought 61 United Therapeutics shares in Q2 2026, an estimated $34.4K.
- United Therapeutics made up 0.03% of First Citizens Bank & Trust's portfolio in Q2 2026, its #216 holding.
- First Citizens Bank & Trust first reported a position in United Therapeutics in Q2 2013 and has held it in 30 quarters since.
- First Citizens Bank & Trust's United Therapeutics position peaked at $2.2M in Q1 2026.
- 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.